HeartMate II LVAS
ABBOTT MEDICAL · Decision date Oct 1, 2026
What did the FDA decide?
The FDA record for P060040/S128, dated 2026-10-01 with decision code OK30, is a 30-Day Notice supplement to the HeartMate II LVAS premarket approval, filed by Abbott Medical under product code DSQ for ventricular assist bypass devices. The stated change is the addition of new top case critical dimensions to be measured, together with a new measurement gauge. The supplement reason is listed as a process change involving manufacturer, sterilizer, packager, or supplier categories.
The record ties this supplement to the original P060040 approval through its identifier, but a supplement is not a new approval of the whole system, and a manufacturing notice is not an original PMA. The statement's purpose covers added inspection measurement only; it does not address clinical safety, effectiveness, or performance of the device itself. What the specific dimensions are, which gauge is used, and how conformity is verified are not described in the supplied fields.
FDA approval order statement
addition of new top case critical dimensions to be measured and a new measurement gauge
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 1, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P060040/S128
- Regulatory pathway
- PMA supplement
- Applicant
- ABBOTT MEDICAL
- Product code
- DSQ
- Decision code
- OK30
- Decision date
- Oct 1, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventricular (assist) bypass.
- Applicant
- Abbott Medical
- Product code
- DSQ
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P060040. Subsequent supplements may change the device or its indications.
FDA decision timeline
P060040 · Original PMA
THORATEC HEARTMATE II LEFT VENTRICULAR ASSIST SYSTEM
P060040/S128 received
Application receipt date recorded by FDA.
P060040/S128 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P060040. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P060040
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| ABBOTT MEDICAL | PMA approval | Apr 21, 2008 | FDA |
Explore the linked device profile
Other records with product code DSQ
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
EXCOR Pediatric Ventricular Assist DeviceP160035/S054 | Berlin Heart, Inc. | PMA supplement | Oct 30, 2026 | FDA |
CentriMag Circulatory Support SystemP170038/S034 | Abbott | PMA supplement | Oct 30, 2026 | FDA |
EXCOR Pediatric VADP160035/S061 | Berlin Heart, Inc. | PMA supplement | Oct 28, 2026 | FDA |
EXCOR Pediatric Ventricular Assist DeviceP160035/S060 | Berlin Heart, Inc. | PMA supplement | Oct 23, 2026 | FDA |
HeartMate 3 Left Ventricular Assist SystemP160054/S136 | ABBOTT MEDICAL | PMA supplement | Oct 19, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Abbott Medical
- Headquarters
- Not reported
- Brand website
- abbott.com
- FDA applicant address
- 6035 Stoneridge Dr., Pleasanton, CA, 94588
Sources and methodology
- Original FDA record: P060040/S128
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records


